Medicine, Cardiology Division

Grants

Grants per year 1999 2014 2015 2016 2017 2018 2019 2020 2021 2031

• 201 Active
• 602 Finished

Grants per year

Search results

• Active

  Rapid Real-Time Cardiovascular MRI for Detecting Coronary Artery Disease

  Kim, D., Lee, D. C., Lee, D. C., Carr, J., Freed, B. H. & Ragin, A.

  National Heart, Lung, and Blood Institute

  9/1/17 → 8/31/22

  Project: Research project

  • Coronary Artery Disease 100%
  • Clinical Protocols 37%
  • Routine Diagnostic Tests 35%
  • Cardiac Arrhythmias 31%
  • Respiration 30%

• ASAP-TOO - Assessment of the WATCHMAN(TM) Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)

  Knight, B. P.

  Boston Scientific Corporation

  7/11/17 → 7/11/23

  Project: Research project

• Northwestern University Molecular and Translational Cardiovascular Training Program

  Ardehali, H., McNally, E. M. & McNally, E. M.

  National Heart, Lung, and Blood Institute

  7/1/17 → 6/30/23

  Project: Research project

  • education programs 100%
  • cardiovascular diseases 47%
  • mentoring 43%
  • funding 31%
  • medicine 25%

• Protocol# 1601: REDUCE II - REDUCE LAP-HF RANDOMIZED TRIAL II: A study to evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure

  Flaherty, J. D. & Ricciardi, M. J.

  Harvard Clinical Research Institute, Corvia Medical, Inc.

  6/6/17 → 6/6/23

  Project: Research project

• Prot# D16900C00053: PRESERVED-HF: Effects of Dapaglifloxin on Biomarkers, Symtoms and Functional Status in Patients with Type 2 Diabetes or Pre-Diabetes, and Preserved Ejection Fraction Heart Failure (PRESERVED-HF TRIAL)

  Khan, S. S. & Shah, S. J.

  Saint Luke's Hospital of Kansas City, AstraZeneca Pharmaceuticals LP

  5/22/17 → 5/22/23

  Project: Research project

• SJM-CIP-10114: AMULET IDE - Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial

  Knight, B. P.

  St. Jude Medical, Inc.

  5/19/17 → 5/19/23

  Project: Research project

• Methods to Improve Personalized Cardiovascular Disease Prevention Across the Life Course

  Zhao, L., Allen, N. B., Liu, K., Liu, L., Lloyd-Jones, D. M. & Wilkins, J. T.

  National Heart, Lung, and Blood Institute

  4/1/17 → 3/31/23

  Project: Research project

  • cardiovascular disease 100%
  • blood pressure 34%
  • life expectancy 22%
  • morbidity 5%
  • Clinical Practice 5%

• Prot# CLN–108: Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation with Focal Impulse and Rotor Modulation Guided Procedures (Redo-FIRM)

  Knight, B. P.

  Topera, Inc.

  2/14/17 → 2/14/23

  Project: Research project

• Study# 2013-05C: Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance after Mitral Valve Replacement with Transcatheter Device

  Davidson, C. J.

  Edwards Lifesciences LLC

  12/6/16 → 12/6/24

  Project: Research project

• Protocol # CIP-09: The REFLECT Trial: A Randomized Evaluation of the TriGuard™ HDH Embolic Deflection Device to Reduce the Impact of Cerebral Embolic Lesions after TransCatheter Aortic Valve Implantation

  Flaherty, J. D.

  Keystone Heart Ltd.

  11/4/16 → 11/4/22

  Project: Research project

• Understanding Outcomes with the EMBLEM™ S-ICD in Primary Prevention Patients with Low Ejection Fraction - UNTOUCHED

  Knight, B. P.

  Cameron Health, Inc.

  9/29/16 → 9/29/22

  Project: Research project

• Prot#B3461045: A Phase 3 Multicenter, Open-Label Study to Evaluate the Safety of Daily Oral Dosing of Tafamidis Meglumine (PF-06291826-83) 20 mg or 80 mg (or Tafamidis(06291826-00) 61 mg) in Subjects Diagnosed With Transthyretin Cardiomyopathy (TTR-CM)

  Shah, S. J.

  PPD Investigator Services, LLC, Pfizer Inc.

  7/27/16 → 7/27/25

  Project: Research project

• Can We Create an Intelligent Echocardiography Device? Testing the Accuracy of Deep Machine Learning in Recognizing Left Ventricular Ejection Fraction in 2-Dimensional Transthoracic Echocardiography.

  Thomas, J. D.

  Bay Labs, Inc.

  6/1/16 → 5/30/24

  Project: Research project

• Association between Biomarkers of Myocardial Injury, Fibrosis, and Neurohormonal Stress with MRI-Based Measures of Myocardial Fibrosis and Myocardial Perfusion

  Lee, D. C.

  Abbott Laboratories

  5/10/16 → 5/31/25

  Project: Research project

• Improved Quantitation of Mitral Regurgitation Before and After MitraClip In vitro and Computational Modeling

  Thomas, J. D. & Wagner, G. J.

  Evalve, Inc.

  4/25/16 → 4/25/23

  Project: Research project

• Protocol #1501:REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure

  Shah, S. J., Pandit, J. A. & Ricciardi, M. J.

  Harvard Clinical Research Institute, Corvia Medical, Inc.

  3/22/16 → 3/22/25

  Project: Research project

• Mechanical circulatory support: Measures of adjustment and quality of life

  Grady, K. L., Hahn, E. A., Bass, M., Cella, D., Condon, D. M., Goetz, P. W., Kallen, M. A., Rich, J. D., Ruo, B. & Yancy, C. W.

  National Heart, Lung, and Blood Institute

  3/7/16 → 2/28/23

  Project: Research project

  • Social Adjustment 100%
  • Heart Failure 97%
  • Quality of Life 73%
  • Equipment and Supplies 45%
  • Technology 37%

• Heart Valve Disease Research Program - IDP Foundation Award

  Thomas, J. D.

  IDP Foundation, Inc.

  3/1/16 → 3/1/23

  Project: Research project

  • cardiovascular disease 100%
  • hardware 95%
  • research program 83%
  • project 76%
  • software 63%

• Protocol #RS-011: aMAZE Study; Left Atrial Appendage Ligation with the LARIAT+® Suture Delivery System as Adjunctive Therapy to Pulmonary Vein Isolation for Persistent or Longstanding Persistent Atrial Fibrillation

  Lin, A. C.

  SentreHEART, Inc.

  1/28/16 → 1/28/25

  Project: Research project

• Prot # 1501:REDUCE LAP-HF RANDOMIZED TRIAL I: A Study to Evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure.

  Shah, S. J.

  Corvia Medical, Inc.

  1/21/16 → 1/21/24

  Project: Research project

• AdaptResponse Study: A Prospective, Randomized, Controlled, Interventional, Single-blinded, Multi-Center, Post-Market, Global Cardiac Resynchronization Therapy (CRT) in Heart Failure (HF) Clinical Study

  Lin, A. C.

  Medtronic, Inc.

  10/5/15 → 10/5/24

  Project: Research project

• The PRAETORIAN trial: A Prospective, Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy

  Chicos, A. B.

  Academic Medical Centre at the University of Amsterdam

  3/27/15 → 3/27/24

  Project: Research project

• Prot # CT-10-05: INTERPRET Cardiac Inotrope Patient Registry Program

  Rich, J. D.

  Coram Clinical Trials, Inc.

  8/25/14 → 8/24/23

  Project: Research project

• Prot # 10-392: ABSORB III Randomized Controlled Trial: Clinical Evaluation of BVS Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions

  Benzuly, K. H., Davidson, C. J. & Ricciardi, M. J.

  Novella Clinical, LLC, Abbott Cardiovascular Systems, Inc.

  6/25/13 → 6/25/25

  Project: Research project

• Prot #11-512:Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional MR Continued Access Study Protocol(the COAPT CAS): A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® Sys

  Flaherty, J. D., Benzuly, K. H., Davidson, C. J., Malaisrie, S. C., Mikati, I. A., Puthumana, J. J., Rigolin, V. H., Sweis, R. N. & Ricciardi, M. J.

  Novella Clinical, LLC, Evalve, Inc.

  10/10/12 → 10/10/24

  Project: Research project